Short term impact of tolvaptan withdrawal in patients with ADPKD.
Phase 4
Recruiting
- Conditions
- Autosomal dominant polycystic kidney disease: ADPKD
- Registration Number
- JPRN-UMIN000033968
- Lead Sponsor
- ippon Medial School Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 9
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who self-suspended hospitalization. Patients who did not obtain consent.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method